When can we hug again? Or dine out? Here's what 500+ epidemiologists said.

As states continue reopening nonessential businesses and easing social distancing measures, many Americans are weighing the risk of resuming activities like eating at a restaurant or getting a haircut. Here's what 511 epidemiologists told the New York Times' "The Upshot" about when they are likely to resume 20 common activities.

Read More

US stocks have regained their 2020 losses—even as WHO warns the Covid-19 pandemic is worsening

The S&P index of top health care companies on Monday closed higher than it had opened for the year, erasing some of the losses recorded in 2020—even as the World Health Organization warned that the new coronavirus pandemic is worsening.

How this 'task force' of 21 priests is bringing last rites to Covid-19 patients

As cases of Covid-19 increased in Boston, the Roman Catholic archbishop established a task force of 21 priests to visit hospitals and safely perform patients' last rites: a Catholic ritual that a priest says can provide "healing" for patients and their families, Elizabeth Dias reports for the New York Times.

Around the nation: Joe Biden secures the Democratic presidential nomination

Biden clinched the nomination on Friday after securing 2,004 delegates through states' primary elections, in today's bite-sized hospital and health industry news from the District of Columbia and Minnesota.

Meet the Covid-19 'long-haulers' whose symptoms won't seem to go away

According to the World Health Organization, patients with Covid-19 typically recover from the disease in about two weeks' time, but there are a number of patients who have had Covid-19 for months—and experts aren't entirely sure why they can't shake the disease.

Covid-19 roundup: AstraZeneca plans to produce 2B doses of its experimental coronavirus vaccine

The Trump administration identifies five companies most likely to produce a vaccine against the new coronavirus, a study finds no benefits associated with treating Covid-19 patients with the anti-malaria drug hydroxychloroquine, and more.